Influence of FTDP-17 mutants on circular tau RNAs.

Circular RNA FTDP-17 Frontotemporal dementia Microtubule associated protein tau RNA editing

Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
27 Jan 2024
Historique:
received: 20 09 2023
revised: 21 12 2023
accepted: 21 01 2024
medline: 30 1 2024
pubmed: 30 1 2024
entrez: 29 1 2024
Statut: aheadofprint

Résumé

At least 53 mutations in the microtubule associated protein tau gene (MAPT) have been identified that cause frontotemporal dementia. 47 of these mutations are localized between exons 7 and 13. They could thus affect the formation of circular RNAs (circRNAs) from the MAPT gene that occurs through backsplicing from exon 12 to either exon 10 or exon 7. We analyzed representative mutants and found that five FTDP-17 mutations increase the formation of 12➔7 circRNA and three different mutations increase the amount of 12➔10 circRNA. CircRNAs are translated after undergoing adenosine to inosine RNA editing, catalyzed by ADAR enzymes. We found that the interferon induced ADAR1-p150 isoform has the strongest effect on circTau RNA translation. ADAR1-p150 activity had a stronger effect on circTau RNA expression and strongly decreased 12➔7 circRNA, but unexpectedly increased 12➔10 circRNA. In both cases, ADAR-activity strongly promoted translation of circTau RNAs. Unexpectedly, we found that the 12➔7 circTau protein interacts with eukaryotic initiation factor 4B (eIF4B), which is reduced by four FTDP-17 mutations located in the second microtubule domain. These are the first studies of the effect of human mutations on circular RNA formation and translation. They show that point mutations influence circRNA expression levels, likely through changes in pre-mRNA structures. The effect of the mutations is surpassed by editing of the circular RNAs, leading to their translation. Thus, circular RNAs and their editing status should be considered when analyzing FTDP-17 mutations.

Identifiants

pubmed: 38286213
pii: S0925-4439(24)00021-8
doi: 10.1016/j.bbadis.2024.167036
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167036

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no financial interests.

Auteurs

Giorgi Margvelani (G)

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.

Justin R Welden (JR)

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.

Andrea Arizaca Maquera (AA)

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.

Jennifer E Van Eyk (JE)

Cedars Sinai Medical Center, Los Angeles, USA.

Christopher Murray (C)

Cedars Sinai Medical Center, Los Angeles, USA.

Sandra C Miranda Sardon (SC)

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.

Stefan Stamm (S)

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. Electronic address: stefan@stamms-lab.net.

Classifications MeSH